Trials / Completed
CompletedNCT05288348
DSUVIA Early Evaluation of Pain Trial
DSUVIA Early Evaluation of PAIN (DEEP) Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Frank Guyette · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Randomized, interventional trial of Emergency Department (ED) administration of DSUVIA (sufentanil) versus standard care pain management comparing pain treatment outcomes in injured patients with moderate to severe pain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sufentanil 30 MCG Sublingual Tablet | 30 microgram sublingual tablet administered using sublingual applicator |
| DRUG | standard care pain treatment | standard care pain treatment given in Emergency Department |
Timeline
- Start date
- 2022-08-05
- Primary completion
- 2024-01-21
- Completion
- 2024-01-21
- First posted
- 2022-03-21
- Last updated
- 2025-04-30
- Results posted
- 2025-04-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05288348. Inclusion in this directory is not an endorsement.